Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Long-Term, Open-Label, Safety Extension Study of Asoprisnil (J867) in Patients With Uterine Leiomyomata

NCT00156182 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00156182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00156182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Long-Term, Open-Label, Safety Extension Study of Asoprisnil (J867) in Patients With Uterine Leiomyomata
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2001
Completion date
December 31, 2001
Enrollment
38 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leiomyoma